How to Cite
Abstract
Phylloides tumors (PT) are a rare and the least studied pathology of the breast. Data on physical examination and imaging methods of diagnostics in most cases do not allow accurate diagnosing at the preoperative stage as there are no clear characteristics that allow differentiating benign from malignant variants of PT or other benign breast diseases. Surgery is the main treatment of PT. Chemotherapy and radiation therapy of malignant variants of PT in the adjuvant setting do not significantly improve survival rates. In recurrent or metastatic forms of PT these methods can be effective in some cases. Currently there are identified molecular signaling pathways that play an important role in the pathogenesis of PT. Thus there are prerequisites for the study of the effectiveness of targeted therapies for this pathology.References
Воротников И.К., Богатырев В.Н., Корженкова Г.П. Листовидные опухоли и саркомы молочных желез: клиника, диагностика, лечение // Маммология. - 2006. - № 1. - С. 20-23.
Григорук О.Г., Богатырев В.Н., Лазарев А.Ф. и др. Цитологическая диагностика листовидных опухолей и сарком молочной железы // Маммология. - 2005. - №1. - С. 30-32.
Летягин В.П., Воротников И.К., Корженкова Г.П. Листовидные опухоли молочных желез // Маммология. - 1997. - № 3. - С. 23-25.
Ржанков С.В., Хачкурузов С.Г. Клинико-рентгенологическая диагностика сарком молочной железы // Клин. мед. - 1978. - № 5. - С. 48-51.
Франк Г.А., Белоус Т.А., Бахмутский Н.Г. Листовидная опухоль и саркома молочной железы //Архив патологии. - 1984. - № 1. - С. 23-30.
Adachi Y, Matsushima T, Kido A. et al. Phyllodes tumor in adolescents. Report of two cases and review of the literature // Breast Dis. - 1993. - Vol. 6. - P. 285-293.
Aranda FI, Laforga JB, Lopez JL. Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblast // Pathol Res Pract. - 1994. - Vol. 190. - P. 474-481.
Azzopardi JG. Sarcoma in the breast // In: Benningron J, ed. Problems in breast pathology. - Philadelphia: WB Saunders. - 1979. - Vol. II. - P. 355-359.
Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors // Ann Surg Oncol. -2009. - Vol. 16. - P. 2288-2294.
Bartoli C, Zurrida S, Veronesi P. et al. Small sized phyllodes tumor of the breast // Eur J Surg Oncol. - 1990. - Vol. 16. - P. 215-219.
Belkacmi Y1, Bousquet G, Marsiglia H. et al. Phyllodes tumor of the breast // Int J Radiat Oncol Biol Phys. -2008. - Vol. 70. - P. 492-500.
Bennett IC, Khan A, DeFreitas R. et al. Phyllodes tumours: a clinicopathological review of 30 cases // Aust N Z J Surg. - 1992. - Vol. 62. - P. 628-633.
Blichert-Toft M, Hansen JP, Hansen OH. et al. Clinical course of cystosarcoma phyllodes related to histologic appearance // Surgery, Gynecology & Obstetrics - 1975. - Vol. 140. -P. 929-932.
Briggs RM, Walters M, Rosenthal D. Cystosarcoma phyllodes in adolescent female patients // Am J Surg. -1983. - Vol. 146. - P. 712-714.
Burton GV, Hart LL, Leight GS Jr. et al. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy // Cancer.-1 Jun 1989. - Vol. 63 (11). - P. 2088-2092.
Chaney AW, Pollack A, McNeese MD. et al. Primary treatment of cystosarcoma phyllodes of the breast // Cancer. - 2000. -Vol. 89. - P. 1520-1511.
Chao TC, Lo YF, Chen SC, Chen MF. Sonographic features of phyllodes tumors of the breast // Ultrasound Obstet Gynecol. - 2002. - Vol. 20. - P. 64-71.
Chen WH, Chen SP, Tzen CY Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases // J. Surg Oncol. - 2005. - Vol. 91. - P. 185-194.
Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes: a review of surgical options // Surgery. - 1989. - Vol. 105. - P. 141-147.
Chua CL. Cystosarcoma phyllodes: Asian variations // Aust N Z f Surg. - 1988. - Vol. 58. - P. 301-305.
Ciatto S, Bonardi R, Cataliotti L. et al. Phyllodes tumour of the breast: a multicenter series of 59 cases // Eur f Surg Oncol. - 1992. - Vol. 18. - P. 549-549.
Cohn-Cedermark G, Rutqvist LE, Rosendahl I. et al. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients // Cancer. -1991. -Vol. 68. - P. 2017-2022.
Confavreux C, Lurkin A, Mitton N. et al. Sarcomas and malignant phyllodes tumours of the breast - a retrospective study // Eur J Cancer. - 2006. - Vol. 42 (16). - P. 2715-2721.
Contarini O, Urdaneta LF, Wayne H. et al. Cystosarcoma phyllodes of the breast: a new therapeutic proposal // Am Surg. - 1982. - Vol. 48. - P. 157-166.
de Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or dearth after surgical resection of phyllodes tumours of the breast // Br J Surg. - 1999. - Vol. 86. -P. 396-399.
Deen SA, McKee GT, Kissin MW. Differential cytologic features of fibroepithelial // Cytopathol. -1999. - Vol. 20. - P. 53-56.
Feakins RM, Mulcahy HE, Nickols CD. et al. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome // Histopathology. - 1999. - Vol. 35. - P. 162-169.
Fou A, Schnabel FR, Hamele-Bena D. et al. Long-term outcomes of malignant phyllodes tumors patients: an institutional experience // Am J Surg. - Oct 2006. - Vol. 192 (4). -P. 492-495.
Foxcroft LM, Evans EB, Porter AJ. Difficulties in the preoperative diagnosis of phyllodes tumors of the breast: a study of 84 cases // Breast. - Feb 2007. - Vol. 16 (1). - P. 27-37.
Franceschini G, Masetti R, Brescia A. et al. Phyllodes tumor of the breast: magnetic resonance imaging findings and surgical treatment // Breast J. Mar-Apr 2005. -Vol. 11 (2). -P. 144-145.
Gordon PB, Gagnon F, Lanzkowsky L, Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up // Radiology. - Oct 2003. - Vol. 229 (1). - P. 223-238.
Grimes MM. Cystosarcoma phyllodes of the breast:histologic features, flow cytometric analysis and clinical correlations // Mod Pathol. - 1992. - Vol. 5. - P. 232-239.
Hart J, Layfield LJ, Trumbull WE. et al. Practical aspects in the diagnosis and management of cystosarcoma phyllodes // Arch Surg. - 1988. - Vol. 123. - P. 1079-1083.
Hawkins RE, Schofield JB, Fisher C. et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes // Cancer. - 1992. - Vol. 69. - P. 141-147.
Inoshita S. Phyllodes tumour (cystosarcoma phyllodes) of the breast: a clinicopathologic study of 45 cases // Acta Pathol Jpn. - 1988. - Vol. 38. - P. 21-33.
Jardim DL1, Conley A, Subbiah V. Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities // Orphanet J Rare Dis. - 2013. - Vol. 8. - P. 112.
Kuijper A1, Snijders AM, Berns EM. et al. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours // Cell Oncol. - 2009. - Vol. 31. - P. 31-39.
Lee JW, Nadelman CM, Hirschowitz SL et al. Malignant phyllodes tumor of a genotypic male, phenotypic female with liposarcomatous differentiation // Breast J. - May-Jun 2007. - Vol. 13 (3). - P. 312-313.
Liberman L, Bonaccio E, Hamele-Bena D et al. Benign and malignant phyllodes tumors: mammographic and sonographic findings // Radiology. - Jan 1996. - Vol. 198 (1). -P. 121-124.
Macdonald OK, Lee CM, Tward JD, Chappel CD. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the surveillance, epidemiology, and end results(SEER) // program. Cancer. - 2006. - Vol. 107. - P. 2127-2133.
Mangi AA, Smith BL, Gadd MA. et al. Surgical management of phyllodes tumors // Arch Surg. - 1999. - Vol. 134. - P. 487-492.
McDivitt RW, Urban JA, Farrow JH. Cystosarcoma phyllodes // Johns Hopkins Med J. - 1987. -Vol. 120. - P. 33-45.
McGregor GI, Knowling MA, Este FA. Sarcoma and cystosarcoma phyllodes tumors of the breast: a retrospective of 58 cases // Am J Surg. - 1994. - Vol. 167. - P. 477-480.
Millar EKA, Beretov J, Marr P. et al. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression // Histopathology. -1999. - Vol. 34. - P. 491-496.
Morales-Vsquez F, Gonzalez-Angulo AM, Broglio K. et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast // Breast J. - Nov-Dec 2007. - Vol. 13 (6). - P. 551-556.
Muller J, Uber den feineren Ban und Die Formen der Krankaften Geschwulste Berlin // G Reiner. - 1838. Vol. 1. - P. 54-57.
Palmer ML, De Risi DC, Pelikan A. et al. Treatment options and recurrence potential for cystosarcoma phyllodes // Surg Gynecol Obstet. - 1990. - Vol. 170. - P. 193-196.
Pandey M., Mathew A., Jayasree K. et al. Malignant phyllodes tumor // The Breast Journal. - 2001. - Vol. 7. - P. 411-416.
Park IH1, Kwon Y, Kim EA. Major response to sunitinib (Sutene) in metastatic malignant phyllodes tumor of breast // Invest New Drugs. - 2009. - Vol. 27. - P. 387-388.
Parker SJ, Harries SA. Phyllodes tumors // Postgrad Med J. - 2001. - Vol. 77. - P. 428-435.
Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women // Am J Clin Pathol. - 1998. - Vol. 22. - P. 64-69.
Rao CR, Narasimhamurthy NK, Jaganathan K. et al. Cystosarcoma phyllodes: diagnosis by fine needle aspiration cytology // Acta Cytol. - 1992. - Vol. 36. - P. 203-207.
Reinfuss M, Mitus J, Duda K. et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases // Cancer. - 1996. - Vol. 77. -P. 910-916.
Rix DB, Tredwell SJ, Forward AD. Cystosarcoma phyllodes (cellular intracanalicular fibroadenoma): clinical- pathological relationships // Can J Surg. - 1971. - Vol. 14. - P. 31-37.
Shabalova IP, Chemeris GJ, Ermilova VD. et al. Phyllodes tumour: cytologic and histologic presentation of 22 cases, and immunohistochemical demonstration of p53 // Cytopathology. - Jun 1997. - Vol. 8 (3). - P. 177-187.
Simi U, Moretti D, Iacconi P. et al. Fine needle aspiration cytopathology of phyllodes tumor // Acta Cytol. - 1988. - Vol. 32. - P. 63-66.
Spitaleri G, Toesca A, Botteri E. et al. Breast Phyllodes tumor: A review of literature and a single center retrospective series analysis // Critical Reviews in Oncology / Hematology. - 2013. - Vol. 88. - P. 427-436.
Tan EY, Tan PH, Yong WS. et al. Recurrent phyllodes tumours of the breast: pathological features and clinical implications // ANZ J Surg. - Jun 2006. - Vol. 76 (6). -P. 467-480.
Tan H, Zhang S, Liu H. et al. Imaging findings in phyllodes tumors of the breast // Eur J Radiol. - Jan 2012. - Vol. 81(1). - P. 62-69.
Tan WJ1, Lai JC, Thike AA et al. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups // Breast Cancer Res Treat. - 2014. -Vol. 145. - P. 635-645.
Tse GM, Chaiwun B, Lau KM et al. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours // J Clin Pathol. - Sep. 2007. -Vol. 60 (9). - P. 1051-1056.
Tse GM, Putti TC, Lui PC. et al. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors // Mod Pathol. - Jul 2004. - Vol. 17 (7). - P. 827-831.
Vorherr H, Vorherr UF, Kutvirt DM. et al. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival // Arch Gynecol. - 1985. -Vol. 236 (3). - P. 173-181.
Wang F, Jia Y, Tong ZS. Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor // Japanese Journal of Clinical Oncology. - 2015. - Vol. 45 (2). - P 146-152.
Ward RM, Evans HL. Cystosarcoma phyllodes. A clinico-pathologic study of 26 cases // Cancer. - 1986. - Vol. 58. - P. 2282-2289.
Wiratkapun C., Piyapan P., Lertsithichai P., Larbcharoensub N. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy // Diagn Interv Radiol. - 2014. - Vol. 20. - P. 27-33.
World Health Organisation. Histological typing of breast tumors // Tumori. - 1982. -Vol. 68. - P. 181-198.
Yabuchi H, Soeda H, Matsuo Y. et al. Phyllodes tumor of the breast: correlation between MR findings and histologic grade // Radiology. - Dec 2006. - Vol. 241 (3). - P. 702-709.
Yamashita J, Ogawa M, Egami H. Abundant expression of immunoreactive endothelin-1 in mammary phyllodes tumour-possible paracrine role of endothelin-1 in the growth of stromal cells in phyllodes tumour // Cancer Res. - 1992. -Vol. 52. - P. 4046-4049.
Yilmaz E, Sal S, Lebe B, Differentiation of phyllodes tumors versus fibroadenomas: mammographic and sonographic features // Acta Radiol. - 2002. - Vol. 43. - P. 34-39.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...